Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GISSI AF valsartan for prevention of atrial fibrillation recurrence
2004-003036-53Phase 3Completed
- Sponsor
- Fondazione ANMCO
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Atrial fibrillation (AFib) comparing Valsartan with Placebo (2 arms). Primary endpoint: Atrial fibrillation recurrence. Started Mar 2005; status: completed.
02
Drugs
valsartan
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2004-003036-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003036-53.